Psilocybin

Mindset Pharma: Approval for Phase II Clinical Trial, MSP-1014 for Treatment of Major Depressive Disorder

Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) announced that it has received approval from the U.K. Medicines and…

June 22, 2023